Xeris Biopharma Holdings, Inc.
XERS
$4.16
$0.215.32%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.15% | 5.19% | -3.84% | -8.15% | -40.60% |
| Total Receivables | 3.11% | -10.50% | 40.41% | 21.24% | 27.14% |
| Inventory | 24.04% | 18.29% | 17.62% | 40.77% | 57.02% |
| Prepaid Expenses | 28.95% | -10.38% | -11.49% | -27.36% | -37.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.29% | 3.00% | 9.37% | 4.69% | -16.35% |
|
|
|||||
| Total Current Assets | 7.29% | 3.00% | 9.37% | 4.69% | -16.35% |
| Net Property, Plant & Equipment | -3.30% | -4.13% | -4.93% | 178.01% | 206.85% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -9.88% | -9.64% | -9.41% | -9.20% | -8.99% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 19.10% | 13.23% | 14.27% | -2.43% | -4.02% |
| Total Assets | 0.14% | -2.04% | 0.90% | 4.75% | -6.36% |
|
|
|||||
| Total Accounts Payable | -80.20% | -38.31% | -50.11% | -40.80% | 151.09% |
| Total Accrued Expenses | 24.40% | 11.97% | 31.21% | 38.54% | 3.57% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 506.07% | 791.76% | 174.26% | 219.34% | 121.20% |
| Total Finance Division Other Current Liabilities | -41.49% | -44.65% | -42.21% | -53.82% | 47.64% |
| Total Other Current Liabilities | -41.49% | -44.65% | -42.21% | -53.82% | 47.64% |
| Total Current Liabilities | 5.52% | 4.57% | -5.26% | -10.24% | 29.30% |
|
|
|||||
| Total Current Liabilities | 5.52% | 4.57% | -5.26% | -10.24% | 29.30% |
| Long-Term Debt | 13.66% | 13.55% | 22.48% | 22.41% | 2.06% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.33% | -4.31% | -2.45% | 268.04% | 269.75% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -76.85% | -24.37% | -11.06% | -33.13% | -70.94% |
| Total Liabilities | 7.07% | 7.87% | 11.39% | 18.70% | 10.04% |
|
|
|||||
| Common Stock & APIC | 5.24% | 5.08% | 4.39% | 4.19% | 1.71% |
| Retained Earnings | -8.89% | -10.46% | -10.07% | -11.27% | -11.22% |
| Treasury Stock & Other | 0.00% | 68.00% | 60.26% | -24.14% | -8.70% |
| Total Common Equity | -336.67% | -832.81% | -241.38% | -130.54% | -115.01% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -336.67% | -832.81% | -241.38% | -130.54% | -115.01% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -336.67% | -832.81% | -241.38% | -130.54% | -115.01% |
|
|
|||||
